Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05240638 · ClinicalTrials.gov registry record · NA
Lymph Drainage in Heart Failure
A NA study of Heart Failure, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT05240638: Completed NA study of Heart Failure, sponsored by Duke University.
NCT05240638 is a NA study of Heart Failure that has completed, run by Duke University. The registered enrollment target is 1 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05240638, a NA study of Heart Failure, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to test the safety and efficacy of lymph fluid drainage on heart congestion and shortness of breath symptoms among patients participants with heart failure.
Primary Outcome
Number of patients where TD was accessed successfully with an endovascular catheter under fluoroscopic or ultrasound guidance
Conditions Studied
Interventions
- DEVICE TD Drainage
Study Locations (1)
North Carolina
- Marat Fudim - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-10-24 |
| Est. Completion | 2023-07-07 |
| Phase | NA |
What the finished NCT05240638 record still lists
NCT05240638 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which TD Drainage is the first listed.
NCT05240638 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05240638 about?
NCT05240638 is a clinical study titled "Lymph Drainage in Heart Failure". This study aims to test the safety and efficacy of lymph fluid drainage on heart congestion and shortness of breath symptoms among patients participants with heart failure.
What is the current status of trial NCT05240638?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2022-10-24. Estimated completion is 2023-07-07.
What conditions does trial NCT05240638 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT05240638?
The interventions under investigation include: TD Drainage (DEVICE).
Who is sponsoring clinical trial NCT05240638?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05240638 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05240638's enrollment target sits among peer trials
1 398th of 397 the lowest of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI